Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Cisplatin Injection, 1 mg/mL, 50 mL/vial & 100 mL/vial, Bedford ANDA 75-036 11/7/00 11/16/00 1/8/02 Cisplatin Injection,1 mg/mL, 50 mL/vial & 100 mL/vial. (tentatively Approved 12/29/98) Bedford ANDA 75-036 12/29/98 12/29 Cisplatin Injection,1 mg/mL, Gensia Sicor ANDA 74-814 5/16/00 5/22/00 Cisplatin Injection,1 mg/mL American Pharmaceutical Partners, ANDA 74-735 7/16/99 7/29/99 Cisplatin Injection,10 mg/vial & 50 mg/vial, Bedford Labs ANDA 74-713 11/14/99 11/17/00 Cisplatin Injection,1 mg/mL, Pharmachemie B.V. ANDA 74-656 Platinol (cisplatin for injection, USP) and Platinol-AQ (cisplatin injection). Bristol-Myers Squibb Company 18-057/S-076 Cisplatin Injection, Bedford Laboratories ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com